Survey of Cancer Survivorship Care

Georgia's Online Cancer Information Center

Survey of Cancer Survivorship Care

7/20/2024

Cancer care providers, we need you!

The Survivorship Working Group of the Georgia Comprehensive Cancer Control Program (GC3) seeks your input regarding your availability to provide medical follow-up for cancer survivors.

  • We define this group as individuals diagnosed with cancer between birth and age 17 (pediatric and adolescent), ages 18-39 (young adult), and age 40 and over (adult), who have completed treatment without evidence of relapse or recurrence at the time of the survey.
  • Individuals with recurrent disease or subsequent cancers may be included if they are not receiving therapy and are tumor-free.

Our simple questionnaire aims to expand care for cancer survivors and identify resources needed by providers who treat them. We understand that venues for long-term follow-up vary by specialty and locale; our goal is to maximize appropriate, culturally sensitive follow-up for survivors as close to home as possible.

Supporting providers is equally important as the number and complexity of survivors grow.

Please share this link with all members of your department who see cancer survivors in Georgia.

Thank you!

Media, News & Events

Georgia CORE launches "Weird Looking Stools" to spark life-saving conversations around the state

With much anticipation, Georgia CORE has launched “Weird Looking Stools,” a statewide awareness campaign using unexpected art to normalize and prompt life-saving conversations about colon cancer and increase voluntary check-ups.

9/19/2025

Lawmakers conclude listening tour on access to cancer care

Rep. Lee Hawkins, R-Gainesville, the committee’s chairman, said he and other lawmakers are working on drug pricing and other issues. He wrapped up the committee’s listening tour by saying the General Assembly will continue to study cancer care access.

7/14/2025

Subscribe to Our Newsletter

Our email newsletter allows you to get the most up-to-date information right in your Inbox.

Subscribe Now